HGHelena Gylling

Helena Gylling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Helena Gylling has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2013
      • Vol. 129  (7) , 756-64

    [Gastric bypass as weight loss operation: 10-year experience of one center and challenges of follow-up].

    by Pirjo Käkelä, Jaana Torpström, Sari Venesmaa, Imre Ilves, Eeva-Liisa Junnila, Kaija Penttinen, Tarja Martikainen, Helena Gylling, Matti Pääkkönen, Jussi Pihlajamäki

    Data about the implementation of long-term follow-up of weight loss operation patients and their nutritional status has been lacking in Finland. We examined the postoperative complications and long-term outcome in respect of weight control, symptoms, nutritional status and medication of 173 patients having undergone gastric bypass. The data were collected from patient records and by questionnaires. Postoperative complications and weight loss were at the international level. The number of those using antidiabetic and antihypertensive drugs decreased. The results are in agreement with the international level, but follow-up treatment requires attention in Finland.

    • 1 January 2013
      • Vol. 129  (24) , 2661-70

    [Fatty fish modifies HDL particle size and lipid concentrations].

    by Laura Joukamo, Maria Lankinen, Ursula Schwab, Pasi Soininen, Antti J Kangas, Marjukka Kolehmainen, Jussi Paananen, Kaisa Poutanen, Hannu Mykkänen, Tuulikki Seppänen-Laakso, et al.

    We investigated with 1HNMR-spectroscopy the effects of habitual fatty fish intake on serum lipiprotein profiles in persons with features of metabolic syndrome. The participants (n = 105) were randomized into three diet intervention groups. The groups were given different dietary instructions. Increased intake of fatty fish had a significant (p < 0.05) increasing effect on the amount of large HDL-lipoprotein subclasses and their lipids. Frequent intake of fatty fish may have beneficial effects on HDL-metabolism beyond that assumed to be related to its serum concentrations.

  • The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins

    by Helena Gylling, Maarit Hallikainen, Markku J. Nissinen, Tatu A. Miettinen


  • Open Access

    Very high plant stanol intake and serum plant stanols and non-cholesterol sterols

    by Helena Gylling, Maarit Hallikainen, Markku J. Nissinen, Piia Simonen, Tatu A. Miettinen

    Today, consumers meet abundant supply of functional foods with plant stanol increments for serum cholesterol lowering purposes. However, efficacy and safety of plant stanols intake beyond 4 g/day have remained unexplored. We evaluated the effects of very high daily intake of plant stanols (8.8 g/day) as esters on cholesterol metabolism, and serum levels of plant sterols and stanols. In a randomized, double-blind, parallel study of 49 hypercholesterolemic subjects (mean age 62 years, range 41–73) consumed a test diet without (control, n = 24), and with added plant stanol esters (staest, n = 25) over 10 weeks followed by 4 weeks on home diet. Serum lipids, lipoprotein lipids, and non-cholesterol sterols were determined at baseline, during intervention, and 4 weeks afterwards. Cholesterol precursor sterol lathosterol reflected cholesterol synthesis, and serum plant sterols and cholestanol mirrored cholesterol absorption. When compared with controls, 8.8 g/day of plant stanols reduced serum and LDL cholesterol by 12 and 17% (P < 0.01 for both). Synthesis marker lathosterol was increased by 30%, while absorption markers decreased up to 62% when compared with controls (P < 0.001 for both). Serum plant stanols increased slightly, but significantly compared with controls (serum sitostanol during intervention, controls: 16 ± 1 μg/dL, staest: 37 ± 2 μg/dL, serum campestanol during intervention, controls: 0.5 ± 0 μg/dL, staest: 9 ± 1 μg/dL, P < 0.001 for both). Changes in serum cholesterol, non-cholesterol sterols, and plant stanols were normalized during post-treatment weeks. Serum plant stanol levels remained at comparable low levels as in studies with daily intake of 2–3 g, and were normalized in 4 weeks suggesting that daily intake of 8.8 g of plant stanols might not increase systemic availability of plant stanols, but reduces effectively serum cholesterol and plant sterol levels.


  • The metabolism of plant sterols is disturbed in postmenopausal women with coronary artery disease

    by Helena Gylling, Maarit Hallikainen, Radhakrishnan A. Rajaratnam, Piia Simonen, Jussi Pihlajamäki, Markku Laakso, Tatu A. Miettinen


  • Open Access

    Long-term consumption of plant stanol and sterol esters, vascular function and genetic regulation

    by Helena Gylling, Maarit Hallikainen, Olli T. Raitakari, Markku Laakso, Erkki Vartiainen, Pia Salo, Vesa Korpelainen, Jouko Sundvall, Tatu A. Miettinen

    Polymorphisms of theABCG5andABCG8genes interfere with cholesterol absorption and synthesis. We determined whether common polymorphisms of these genes regulate the responses of serum cholesterol and vascular function during long-term inhibition of cholesterol absorption. Mildly to moderately hypercholesterolaemic subjects (n282) completed a 1-year study consuming plant stanol or sterol ester (2 g stanol or sterol) or control spread. Serum cholesterol and non-cholesterol sterols, markers of cholesterol absorption and synthesis, and variables of vascular function and structure were analysed in relation to common polymorphisms ofABCG5andABCG8. At baseline, subjects with the 54K allele ofABCG8had higher brachial endothelial-dependent flow-mediated dilatation than those without it (5·79 (se0·31)v.4·46 (se0·44) %;P = 0·049), and subjects with the 632V allele ofABCG8had larger brachial artery diameter than those without it. Polymorphisms ofABCG5andABCG8were neither associated with serum cholesterol reduction nor changes in cholesterol metabolism or in vascular function. However, in subjects with the 400K allele ofABCG8, intima media thickness (IMT) was increased in all groups more than in those without it (P < 0·05). In conclusion, serum cholesterol lowering with absorption inhibition was not associated with polymorphic sites ofABCG5andABCG8. However, regulation of baseline cholesterol metabolism and vascular function and structure, and IMT progression during 1 year seemed to share some of the common polymorphic sites of these genes, suggesting a gene-regulated interaction between cholesterol metabolism and vascular function and structure.


  • Open Access

    Plant stanol ester consumption and arterial elasticity and endothelial function

    by Olli T. Raitakari, Pia Salo, Helena Gylling, Tatu A. Miettinen

    We evaluated whether plant stanol esters mixed with different vegetable oil spreads improved arterial health. A total of 200 adults with serum cholesterol >5 mmol/l were randomised to consume camelina, rapeseed or sunflower oil spread with stanol (2 g/d) ester or sunflower oil spread without stanol ester (controls) for 3 months. Non-invasive ultrasound was used to measure carotid artery compliance (CAC) and brachial artery flow-mediated endothelial dependent vasodilatation (FMD) at baseline and after the intervention as markers of arterial health. Plant stanol esters reduced LDL-cholesterol by 9 % compared with controls (P < 0·001) similarly in the different treatment groups. In the combined treatment groups (n 147), CAC or FMD were not changed from controls (n 47). In a subgroup analysis, division of subjects at baseline into below and over sex-specific 50th percentiles of CAC and FMD revealed that low CAC was improved from 1·23 to 1·59 % per 10 mmHg in the treatment group (n 69), and from 1·42 to 1·47 % per 10 mmHg in controls (n 25), (P = 0·0035 between groups). Low FMD was improved from 6·9 % to 8·6 % in the treatment group (n 73) and from 6·6 % to 6·8 % in controls (n 24) (P = 0·05 between groups). In the respective high-median groups, CAC and FMD were not changed in spite of significantly lowered LDL-cholesterol. In conclusion, consumption of plant stanol ester for 3 months had no overall significant effect on arterial elasticity and endothelial function. A controlled study is needed to test whether beneficial changes are obtained in subjects with initially reduced arterial elasticity and endothelial function.


  • Cholesterol synthesis prevails over absorption in metabolic syndrome

    by Helena Gylling, Maarit Hallikainen, Marjukka Kolehmainen, Leena Toppinen, Jussi Pihlajamäki, Hannu Mykkänen, Jyrki J. Ågren, Rainer Rauramaa, Markku Laakso, Tatu A. Miettinen